149 related articles for article (PubMed ID: 36036623)
1. A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients.
Salar-Behzadi S; Corzo C; Laggner P
J Vis Exp; 2022 Aug; (186):. PubMed ID: 36036623
[TBL] [Abstract][Full Text] [Related]
2. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
Corzo C; Meindl C; Lochmann D; Reyer S; Salar-Behzadi S
Eur J Pharm Biopharm; 2020 Jul; 152():44-55. PubMed ID: 32387704
[TBL] [Abstract][Full Text] [Related]
3. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 2: Application of polyglycerol esters of fatty acids as hot melt coating excipients.
Salar-Behzadi S; Corzo C; Gomes Lopes D; Meindl C; Lochmann D; Reyer S
Eur J Pharm Biopharm; 2020 Mar; 148():107-117. PubMed ID: 31982575
[TBL] [Abstract][Full Text] [Related]
4. The impact of particle preparation methods and polymorphic stability of lipid excipients on protein distribution in microparticles.
Liu J; Christophersen PC; Yang M; Nielsen HM; Mu H
Drug Dev Ind Pharm; 2017 Dec; 43(12):2032-2042. PubMed ID: 28756687
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the solid state of lipid coating and release profile of API from hot melt coated microcapsules.
Salar-Behzadi S; Corzo C; Schaden L; Laggner P; Zimmer A
Int J Pharm; 2019 Jun; 565():569-578. PubMed ID: 31100383
[TBL] [Abstract][Full Text] [Related]
6. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 1: Screening of solid-state and physical properties of polyglycerol esters of fatty acids as advanced pharmaceutical excipients.
Corzo C; Lopes DG; Lochmann D; Reyer S; Stehr M; Salar-Behzadi S
Eur J Pharm Biopharm; 2020 Mar; 148():134-147. PubMed ID: 31982573
[TBL] [Abstract][Full Text] [Related]
7. Impact of Surface Properties of Core Material on the Stability of Hot Melt-Coated Multiparticulate Systems.
Schertel S; Salar-Behzadi S; Zimmer A
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802098
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
9. Flow-through cross-polarized imaging as a new tool to overcome the analytical sensitivity challenges of a low-dose crystalline compound in a lipid matrix.
Adler C; Schönenberger M; Teleki A; Leuenberger B; Kuentz M
J Pharm Biomed Anal; 2015 Nov; 115():20-30. PubMed ID: 26142560
[TBL] [Abstract][Full Text] [Related]
10. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
Windbergs M; Strachan CJ; Kleinebudde P
Eur J Pharm Biopharm; 2009 Jan; 71(1):80-7. PubMed ID: 18588976
[TBL] [Abstract][Full Text] [Related]
11. Role of water in the physical stability of solid dosage formulations.
Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
13. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
14. Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems.
Attama AA; Schicke BC; Müller-Goymann CC
Eur J Pharm Biopharm; 2006 Nov; 64(3):294-306. PubMed ID: 16949805
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Amorphous Solid Dispersions and Identification of Low Levels of Crystallinity by Transmission Electron Microscopy.
S'ari M; Blade H; Cosgrove S; Drummond-Brydson R; Hondow N; Hughes LP; Brown A
Mol Pharm; 2021 May; 18(5):1905-1919. PubMed ID: 33797925
[TBL] [Abstract][Full Text] [Related]
16. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
17. Impact of polysorbate 65 on tripalmitin crystal growth and release stability of hot melt coated multiparticulate systems.
Schertel S; Salar-Behzadi S; Karrer J; Laggner P; Zimmer A
Int J Pharm; 2021 Sep; 607():120970. PubMed ID: 34363917
[TBL] [Abstract][Full Text] [Related]
18. Preformulation studies of efavirenz with lipid excipients using thermal and spectroscopic techniques.
Makoni PA; Kasongo KW; Walker RB
Pharmazie; 2020 Sep; 75(9):417-423. PubMed ID: 32797766
[TBL] [Abstract][Full Text] [Related]
19. Effect of solid state transition on the physical stability of suspensions containing bupivacaine lipid microparticles.
Li LC; Zhu L; Song JF; Deng JS; Bandopadhyay R; Wurster DE
Pharm Dev Technol; 2005; 10(2):309-18. PubMed ID: 15926680
[TBL] [Abstract][Full Text] [Related]
20. Microphase separation in solid lipid dosage forms as the cause of drug release instability.
Lopes DG; Koutsamanis I; Becker K; Scheibelhofer O; Laggner P; Haack D; Stehr M; Zimmer A; Salar-Behzadi S
Int J Pharm; 2017 Jan; 517(1-2):403-412. PubMed ID: 28007547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
